These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2569630)

  • 1. Epstein-Barr virus/complement receptor and epithelial cells.
    Lancet; 1989 Aug; 2(8660):448-50. PubMed ID: 2569630
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of the complement (CD21)/Epstein-Barr virus receptor in human lacrimal gland and ocular surface epithelia.
    Levine J; Pflugfelder SC; Yen M; Crouse CA; Atherton SS
    Reg Immunol; 1990-1991; 3(4):164-70. PubMed ID: 1966579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus/complement receptor and epithelial cells.
    Niedobitek G; Herbst H; Stein H
    Lancet; 1989 Jul; 2(8654):110. PubMed ID: 2567860
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids.
    Jønsson V; Wells A; Klein G
    Cell Immunol; 1982 Sep; 72(2):263-76. PubMed ID: 6983911
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: implications for the relationship between African and American Burkitt's lymphoma.
    Freeman CB; Magrath IT; Benjamin D; Makuch R; Douglass EC; Santaella ML
    Clin Immunol Immunopathol; 1982 Oct; 25(1):103-13. PubMed ID: 7151335
    [No Abstract]   [Full Text] [Related]  

  • 7. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2).
    Siaw MF; Nemerow GR; Cooper NR
    J Immunol; 1986 Jun; 136(11):4146-51. PubMed ID: 3009616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus receptors on human pharyngeal epithelia.
    Young LS; Clark D; Sixbey JW; Rickinson AB
    Lancet; 1986 Feb; 1(8475):240-2. PubMed ID: 2868257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of C3dg/Epstein-Barr virus receptors on human B cells and B cell lines.
    Rasmussen JM; Marquart HV; Rask R; Jepsen HH; Svehag SE
    Complement; 1988; 5(2):98-107. PubMed ID: 2837360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
    Takimoto T; Umeda R; Glaser R
    Acta Virol; 1989 Aug; 33(4):375-7. PubMed ID: 2574946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the Epstein-Barr virus receptor found on Raji cells. I. Extraction of receptor and preparation of anti-receptor antibody.
    Simmons JG; Hutt-Fletcher LM; Fowler E; Feighny RJ
    J Immunol; 1983 Mar; 130(3):1303-8. PubMed ID: 6337215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C3d,g/Epstein-Barr virus receptor density on human B-lymphocytes estimated by immunoenzymatic assay and immunocytochemistry.
    Rask R; Rasmussen JM; Hansen HV; Bysted P; Svehag SE
    J Clin Lab Immunol; 1988 Mar; 25(3):153-6. PubMed ID: 2969415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of the purified Epstein Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions.
    Mold C; Cooper NR; Nemerow GR
    J Immunol; 1986 Jun; 136(11):4140-5. PubMed ID: 3009615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines.
    Yamamoto N; Mitsuma T; Vogt A
    J Natl Cancer Inst; 1982 Mar; 68(3):385-90. PubMed ID: 6278193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.
    Cooper NR; Moore MD; Nemerow GR
    Annu Rev Immunol; 1988; 6():85-113. PubMed ID: 2838050
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
    Hedrick JA; Watry D; Speiser C; O'Donnell P; Lambris JD; Tsoukas CD
    Eur J Immunol; 1992 May; 22(5):1123-31. PubMed ID: 1315687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus infection and replication in a human epithelial cell system.
    Li QX; Young LS; Niedobitek G; Dawson CW; Birkenbach M; Wang F; Rickinson AB
    Nature; 1992 Mar; 356(6367):347-50. PubMed ID: 1312681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular receptor for Epstein-Barr virus.
    McClure JE
    Prog Med Virol; 1992; 39():116-38. PubMed ID: 1317595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.